STSP-0601 clinical trials
How each study uses STSP-0601 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- STSP-0601 for Injection
- 5
Studies by the year they started
5 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Staidson (Beijing) Biopharmaceuticals Co., Ltd (4) · Jiangsu BioJeTay Biotechnology Co., Ltd. (1)
Studies
Open first, then newest update. How each study uses STSP-0601 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia PatientsActive, not recruitingPhase 3Jiangsu BioJeTay Biotechnology Co., Ltd.NCT06922045Written as STSP-0601 for Injection
- Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with InhibitorCompletedPhase 2Staidson (Beijing) Biopharmaceuticals Co., LtdNCT06289166Written as STSP-0601 for Injection
- A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With InhibitorCompletedPhase 1/2Staidson (Beijing) Biopharmaceuticals Co., LtdNCT05027230Written as STSP-0601 for Injection
- A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With InhibitorCompletedPhase 1Staidson (Beijing) Biopharmaceuticals Co., LtdNCT04747964Written as STSP-0601 for Injection
- Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without InhibitorCompletedPhase 2Staidson (Beijing) Biopharmaceuticals Co., LtdNCT05619926Written as STSP-0601 for Injection